100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Summary IB Abnormal Psychology - Treatments for Depression $7.49   Add to cart

Summary

Summary IB Abnormal Psychology - Treatments for Depression

 15 views  0 purchase
  • Course
  • Institution

A summary of the biological and cognitive treatments for depression and the supporting studies relevant to the IB Psychology Abnormal Psychology option. The document also includes critical analysis points and research (including the role of culture in treatment)

Preview 2 out of 7  pages

  • May 30, 2022
  • 7
  • 2021/2022
  • Summary
  • Secondary school
  • 5
avatar-seller
Biological Treatments of Depression

Biomedical approaches to treatment are based on the assumption that if the problem is based on
biological malfunctioning, drugs should be used to restore the biological system.

SSRIs (Selective Serotonin Reuptake Inhibitors)

They are drugs that selectively affect only the reuptake pumps for serotonin
- A change from an earlier antidepressant that affected a mix of neurotransmitters.
SSRIs are a development of earlier antidepressants as they are less toxic, have less addictive properties and have fewer
negative side effects.


Key Study: Elkin et al (1999)

Aim To investigate the effectiveness of three approaches to therapy for depression


Method and 28 clinicians worked with 250 depression patients who were randomly assigned to one of three
participants treatment conditions for 16 weeks.
1) Interpersonal therapy
2) Cognitive Behavioural Therapy
3) Antidepressant medication
4) Placebo medication

Patients were assessed by symptoms and life function by a clinician who was blind to their treatment.

Results Patients in all treatment groups showed an improvement in symptoms over 16 weeks.
Antidepressants were the most effective and best for severe cases of MDD
Placebos performed the worse compared to both therapy styles and antidepressants

Conclusions Drugs are a faster and superior treatment than placebo and CBT, but only in severe cases otherwise,
differences are not significant.

Critical ● Ethics of placebo → participants expecting a treatment but intentionally not being given one
Thinking ● Psychotherapy is not standardised so not cannot guarantee that everyone in that condition
received the same treatment
MAGEC ● There may have been a “third-variable” which caused the depression symptoms to reduce →
sometimes depression goes away on its own with time


Key Study: Kirsch et al. → Antidepressant effects can be duplicated with a Placebo

Aim To investigate the effectiveness of antidepressants in comparison to placebo


Method and Conducted a meta-analysis of published and unpublished data on the effectiveness of antidepressants
participants

Results 82% of the effect on antidepressants was duplicated by the placebo

, Critical ● In many clinically blind trials the clinicians and patients sometimes work out which condition
Thinking they have been assigned to causing experimenter bias and demand characteristics
● Antidepressants interfere with the brain’s natural self-regulation processes making an
MAGEC individual more vulnerable to depression in the future.
● Study shows that antidepressants should not be prescribed as much as they are


Study: Cusin - Pramipexole, a Dopamine Agonist

Related concept(s): Pramipexole is an exogenous antagonist that binds to dopamine receptors and mimics their action to
increase activity of dopamine systems

Aim Investigate the effectiveness of pramipexole as a dopamine agonist to treat depression symptoms linked
to low dopamine levels

Method and A randomised controlled trial with “treatment-resistant” participants (ie. SSRI’s didn’t improve their
participants symptoms). Participants took a pramipexole or placebo for 8 weeks.
Depression symptoms measured with MADRS scale before treatment and after 8 weeks.

Results There was a significant reduction in MDD symptoms in pramipexole conditions

Conclusions Increasing dopamine activity with agonist pramipexole may alleviate symptoms of depression by
returning pleasurable experiences

Critical ● What happens to depressed patients when they stop taking the agonist? They may be subject to
Thinking relapses and withdrawal symptoms
● Provides evidence for the role of dopamine in causing depression
MAGEC ● Practical application of agonists to treat issues caused by the low level of neurotransmitter: eg.
Parkinson's and depression

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller raniyahbasheer. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $7.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

82292 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$7.49
  • (0)
  Add to cart